Site icon pharmaceutical daily

Two Day Virtual Clinical Trials Connect Conference 2021: Futuristic Advancements in Clinical Trials and Clinical Research – May 5th-6th, 2021 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Clinical Trials Connect 2021” conference has been added to ResearchAndMarkets.com’s offering.

The 4th Annual Global Clinical Trials Connect 2021 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research.

This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.

The Pharma and Bio-Tech companies are consistently evolving and new clinical studies, technologies and advancements in care and treatments have augmented the efficiency and at the same time, the complexity of clinical trials has increased, with tests being carried out in a highly structured and closely coordinated manner. It is high time that we look into innovative strategies, new technologies, effective and quality collaborations to address these issues, which can cater to the needs of the patient and the industry.

This conference intends to focus on the global health and clinical trials around the world. Bioethics, regulations, patient recruitment, site selection, real-world data, data integration & Strategy, outsourcing, vendor management, quality (QbD) in Trial Conduct, risk-based monitoring, clinical auditing & financial planning and other significant topics that play a key role in clinical trials will be addressed along with innovative sessions on new technologies, effective and quality collaborations.

This program will certainly educate health care scientists on trial design, operations, organizing trials, research computing, regulatory aspects, report on clinical trials and gain a better knowledge of the implications of clinical trials in prevention, diagnosis, clinical trial-related ethics and disease treatments.

The Virtual summit will facilitate an invaluable networking opportunities with Decision makers and Industry experts, focusing on real case studies and insightful presentations. Bringing in Exciting features like Q&A Sessions with industry experts, Networking Video Chat, Polling, Raise Hand, Virtual Exhibitor booths with waiting room/tables and virtual chat, Peer to Peer connect at Social Lounge, Handout Bags and more giving opportunity to grow and expand your networking throughout the event

Key Highlights

Who Should Attend:

This event is designed for senior-level attendees from various companies including Pharmaceutical, Bio-Tech, Bio-Pharma, CRO’s, Investigative Sites, Solution provider and Government institutions.

Attendees include VPs, GMs, Directors, Heads and Managers of

Speakers

Daniel De Schryver

Patient Engagement & Advocacy Lead, EMEA

Janssen Pharmaceutical

Catherine O’Connor

Director, Global Clinical Research

Gilead Sciences

Adama Ibrahim

Director, Digital Solutions (Global Drug Development)

Novartis

Bodo Lutz

Global Risk Management, Data Integrity, and Quality Assurance

Novartis

Ana Herradon Virseda

Associate Director, Monitoring Manager

Bristol-Myers Squibb

Maria Kuthning

Clinical Program Leader

Sobi – Swedish Orphan Biovitrum AB (publ)

Pawel Wojcik

Associate Director Study Management (Clinical Operations, R&D Oncology)

Astrazeneca

Maria Palombini

Leader, Healthcare Life Sciences Practice

IEEE Standards Association

Tamzin Blagbrough

Sourcing consultant

Eli Lilly

Sol Yates

Associate Director Regulatory Affairs Development

Grunenthal

Veronique Freund

Head of Clinical External Parties Quality Management

Sanofi

Edyta Zbirog-Lukawska

Central Europe Quality And Compliance Adviser (Affiliate Process and Training Adviser)

Roche

Lucy Hampshire

Senior Director, Medicines Quality

Eli Lilly and Company

Karen Hue

Senior GxP Consultant

30 TECHNOLOGY

Devaki Nair

Clinical Lead for Clinical Biochemistry and HOD – Director SAS Centre for Cardiac Biomarkers

NHS

Ellen Van Vijnckt

Head Start-Up & Admin Team Country Clinical Operations

Roche

Vladimir Anisimov

Principal Data Scientist | Data Science | Center for Design & Analysis

Amgen

Nancy Meyerson-Hess

Chief Compliance and Regulatory Officer

eMQT

Kylie Gyertson

Head of Cancer Clinical Trials Unit

UCLH

Tim Cave

SaySo Medical CEO & Founder

SaySo Medical

Marc Ditmarsch

VP Clinical & Operations

NewAmsterdam Pharma

Gareth Powell

Business Development Officer

NIHR

For more information about this conference visit https://www.researchandmarkets.com/r/44t8t7

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version